Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/24/18
End: 01/31/22
Due: 01/31/23
Phase: N/A
Priority: Normal
Start: 05/07/19
End: 11/08/21
Due: 11/08/22
Phase: N/A
Priority: Normal
Start: 02/21/22
End: 01/31/25
Due: 01/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Trial of AB-110 in Adults With Hematologic Malignancies Undergoing Cord Blood Transplantation | NCT03483324 | Angiocrine Bioscience | user2@example.com | None | 2018-04-24 | 2022-01-31 | 2023-01-31 | - | - | 2025-07-14 |
| Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation | NCT03925935 | Angiocrine Bioscience | user2@example.com | None | 2019-05-07 | 2021-11-08 | 2022-11-08 | - | - | 2025-07-14 |
| A Study of the Effects of AB-205 in Patients With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation | NCT05181540 | Angiocrine Bioscience | user2@example.com | None | 2022-02-21 | 2025-01-31 | 2026-01-31 | - | - | 2025-07-14 |